Table 3

Attitudes, practices and opinion of midwives toward cervical cancer prevention by category of health facility, Abidjan, Côte d’Ivoire, 2012
Total UH GH PHC P SoM P*
N = 592 (%) n = 125 (%) n = 134 (%) n = 194 (%) n = 139 (%)
Midwives screened 112 (18.9) 39 (31.2) 26 (19.4) 32 (16.5) <0.01 15 (10.8) <0.01
Type of test (N = 112) NA NA
Pap smear 80 (13.5) 29 (74.4) 19 (73.1) 27 (84.4) 5 (33.3)
VIA 29 (4.9) 8 (20.5) 7 (26.9) 5 (15.6) 9 (60.0)
Ignore it** 3 (2.7) 2 (5.1) 0 (0.0) 0 (0.0) 1 (6.7)
Practice of screening
Propose screening to women 223 (37.7) 57 (45.6) 62 (46.3) 53 (27.3) <0.01 51 (36.7) <0.01
Had already performed visual inspection 50 (8.4) 12 (9.6) 16 (11.9) 11 (5.7) 0.12 11 (7.9) 0.22
Opinion on the HPV vaccine (N = 298)
Protect against cervical cancer 224 (75.2) 64 (80.0) 47 (79.7) 75 (81.5) 0.01 38 (56.7) <0.01
Available in Côte d’Ivoire 158 (53.0) 42 (52.5) 39 (66.1) 47 (51.1) 0.12 30 (44.8) 0.11
Dangerous for health 10 (3.4) 2 (2.5) 3 (5.1) 4 (4.3) NA 1 (1.5) NA
Expensive 8 (2.7) 2 (2.5) 2 (3.4) 3 (3.3) NA 1 (1.5) NA
Will recommend it 211 (70.8) 59 (73.8) 45 (76.3) 74 (80.4) 0.10 33 (49.3) <0.01

UH: University Hospital; GH: General Hospital; PHC: Primary Health Center; SoM: School of Midwifery; p: comparison of responses between UH, GH and PHC (student excluded). P*: comparison of the four groups of midwives. Ignore it**: respondents report that the test was neither pap smear nor VIA, but were unable to remember the name of the screening test they benefited from. NA: Chi2 test Not Applicable.

Tchounga et al.

Tchounga et al. BMC Health Services Research 2014 14:165   doi:10.1186/1472-6963-14-165

Open Data